Supplementary proposals of the Nomination Committee for the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
41
Supplementary proposals of the Nomination Committee for the 2017 Annual General Meeting

Uppsala, Sweden, 2017-09-21 08:15 CEST (GLOBE NEWSWIRE) -- For the AGM on September 25, 2017, the Board of Oasmia Pharmaceutical AB has been informed by the company's Nomination Committee of the following.

The Nomination Committee proposes that the Board to be composed of five directors elected at the AGM, with no alternates, for the period until the next AGM.

The Nomination Committee proposes re-election of Julian Aleksov, Lars Bergkvist, Bo Cederstrand and Alexander Kotsinas as directors. The Nomination Committee proposes Per Langö to be elected as new director. It is proposed that Julian Aleksov be re-elected Chairman of the Board.

Per Langö has extensive experience in launching and establishing global products in various therapeutic areas. Mr Langö is currently employed by the Nestle Skin Health and lives and works in the USA. He holds an MSc in Business Studies and Economics from Uppsala University.

The Nomination Committee proposes that Board members shall receive remuneration of SEK 150,000 per year, with the exception of the Chairman of the Board, who shall receive remuneration of SEK 300,000 per year. However, board members who receive other salary or other remuneration from the company shall not receive board fees.

The Nomination Committee has previously submitted a proposal for a resolution on the Nomination Committee, which was included in the notice of the AGM and was presented in the Nomination Committee's proposal on the company's website. However, the Nomination Committee has decided to amend its proposal to delete the following two sentences: “The members of the Board shall not constitute a majority of the members of the nomination committee.” and “The Chairman of the Board, or any other member of the Board, may not be the Chairman of the nomination committee.”

The Nomination Committee for the AGM 2017 comprises the following members: Julian Aleksov (Chairman of the Nomination Committee), representing Alceco S.A., Bo Cederstrand, representing Alceco S.A. and Per Arwidsson, representing Granitplattan AB.

The Nomination Committee´s other proposals for the AGM on September 25, 2017 and the statement on the proposed Board are available on the company’s website www.oasmia.com

About Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics which, in comparison with current alternatives, show improved properties, reduced side-effects, and expanded applications. The company’s product development is based on its proprietary in-house research and company patents. Oasmia is listed on NASDAQ Capital Markets (OASM.US), Frankfurt Stock Exchange (OMAX.GR, ISIN SE0000722365) and NASDAQ Stockholm (OASM.ST).

         For more information, please contact:          Julian Aleksov, Chairman of the Nomination Committee          Tel : +4618 - 50 54 40          E-mail: julian.aleksov@oasmia.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL CSOT's OLED Move In Marks Next Phase of Growth

Updated Category News Views 96

A Landmark Moment in OLED Manufacturing Alright, let me drop a quick line here. TCL CSOT just shifted gears with their t8 production line in Guangzhou. It’s not your typical assembly line story—this one's all about pulling the future into the present. We're talking the world's first 8.6-generation Inkjet Printing OLED production line, for crying out loud. They've just...

Continue Reading
Triller's Bumpy Ride: Legal Woes and Investor Action

Updated Category News Views 124

Triller's Stock Roller Coaster Ah, Triller Group Inc., a name that might've gotten you excited once, but now it's like a bad Hollywood sequel. Picture this: you're holding onto shares like a rookie chilling in the shark-infested waters, and now they're caught in a swirling mess of legal jazz and stock tumbles. It's not pretty, folks. We're talking about the whole nine...

Continue Reading
Alley Cat Allies Sues Lincolnton Over Cat Shooting

Updated Category News Views 404

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...

Continue Reading
IAN Aims to Redefine Longevity, Unveils Health Gummies

Updated Category News Views 41

New Chapter in Wellness: Welcome IAN Here's a kicker for you—IAN, a fresh face in the bustling wellness arena, is setting out to change how we look at aging. Founded by Richard Laver, who's been around the block with some heavy hitters like Kate Farms, IAN is making its mark with a unique product—a daily stack gummy launching this December 22. This isn't your...

Continue Reading
Buying a Home in East Grand Rapids: Key Tips Revealed

Updated Category News Views 76

Navigating East Grand Rapids Housing Market Jumping into the housing market in East Grand Rapids, Michigan, is like diving headfirst into a spirited game of musical chairs. Blink, and that dream property might have slipped through your fingers. The competition here is fierce, and if you're not coming prepared, you're setting yourself up for a world of disappointment....

Continue Reading
Louisiana's Musical Legacy Gets a Boost from Foundation

Updated Category News Views 110

Preserving the Tunes of the Bayou Well, if that ain't music to your ears! The Louisiana First Horizon Foundation is sliding into the spotlight with news that's bound to strike a chord with any lover of the state's iconic rhythms. They're diving in deep, backing the Louisiana Music Museum right in the heart of Lafayette. Now, that ain't just another charity stunt; it's a...

Continue Reading
ACR Poker's $20M OSS Leads High-Stakes Weekend

Updated Category News Views 91

Sunday Showdown at ACR: A Massive Poker Feast Kicking off the action on November 8, ACR Poker brings its Online Super Series (OSS) into the spotlight, and listen up—there's a cool $20 million spread on the table through November 24. What's got people really tuned in, though, is the mix of big stakes, high tension events, and a shot at paradise over in the Bahamas....

Continue Reading
BlackLine's SAP Woes Spark Investor Scrutiny

Updated Category News Views 79

What Triggered This Investigation? Here we go again, folks. BlackLine's taking a hit, and it ain't pretty. They're reeling from a whopping 17.4% drop in their share price after cutting their fiscal 2026 outlook. You can bet the folks with stakes in BlackLine (NASDAQ:BL) are feeling the burn. This all comes down to a mess involving their SAP SolEx channel. Let's dive into...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 29

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Hyperstar's Bold Push: Sales Over Follower Hype

Updated Category News Views 121

A New Era in Influencer Marketing: Hyperstar's Gamble Here's a kicker—follower count is starting to take the back seat, and it's about darn time. Over in Seoul, Hyperstar is shaking up the influencer marketing scene with a new laser focus: not who's got the biggest podium, but who can actually move the product. CEO Euychul Shin seems bent on rewriting the playbook. He...

Continue Reading

Top 5 Most Recently Viewed Articles

Harris & Harris Group Navigates Market Challenges as TURN Hits Low

Updated Category News Views 193

Market Challenges Impacting Harris & Harris Group In the current challenging market landscape, shares of Harris & Harris Group, Inc. (NASDAQ: TURN) have hit a 52-week low of $3.3. This investment firm, known for its venture capital endeavors, has encountered substantial difficulties over the past year, evidenced by a notable decline of 19.76%. Such a downturn reflects...

Continue Reading
Purdue Innovates Fast Lead Detection for Healthier Communities

Updated Category News Views 214

Innovative Approaches for Lead Exposure Detection Lead exposure can have serious consequences on health, and it is crucial to have effective methods for its detection. A team at Purdue University has pioneered transformative technologies that streamline the process of measuring lead exposure in blood and bone tissues. The innovations developed offer significant benefits...

Continue Reading
Devon Energy's Upcoming Fireside Chat at J.P. Morgan Conference

Updated Category News Views 195

Devon Energy Engages with Investors at J.P. Morgan Conference Devon Energy Corp. (NYSE: DVN) is gearing up for an exciting opportunity to engage directly with investors. Clay Gaspar, the company’s President and CEO, will be participating in a fireside chat at the prestigious J.P. Morgan Energy, Power, Renewables & Mining Conference. This event promises to be informative...

Continue Reading
Spanish Stock Market Dynamics: Key Highlights and Trends

Updated Category News Views 384

Recent Developments in the Spanish Stock Market The Spanish stock market experienced a downturn recently, closing lower amid notable sectoral losses. The primary sectors that faced declines included Telecoms & IT, Building & Construction, and Chemical, Petroleum & Plastic. These pullbacks adversely affected many stocks, particularly within the IBEX 35 index. IBEX 35...

Continue Reading
Oppenheimer Keeps GDEV Stock Rating Amid Growth Potential

Updated Category News Views 73

Oppenheimer Maintains Perform Rating on GDEV Inc. Oppenheimer has decided to keep its Perform rating on shares of GDEV Inc. (NASDAQ: GDEV), focusing on the exciting growth avenues being explored for the company's PG3 game. The firm notes that while PG3 currently constitutes less than 10% of GDEV's overall revenues, it is strategically placed for future expansion. Future...

Continue Reading